活性位检测检测标准活性位检测-中析研究所检测

(CMA)

(CNAS)

(ISO)

(高新技术企业)

活性位检测相关标准参考信息

GB/T 41906-2022 超氧化物歧化酶活性检测方法
简介：
信息：ICS：07.080 CCS：C27 发布：2022-10-12 实施：2022-10-12

DIN EN ISO 16256-2013 临床实验室测试和体外诊断试验系统.检测体外抗菌剂抗传染病中酵母菌的活性的标准方法(ISO 16256-2012).德文版本EN ISO 16256-2012
简介：
信息：ICS：11.100.10 CCS：C38 发布：2013-04 实施：

NP 698-1987 食用型微生物．特殊植物活性酸乳酪的检测
简介：A presente Norma destina-se a estabelecer um processo expedito para verificar a vitalidade das bactérias que constituem a flora específica do iogurte.Aplica-se a todos os tipos de iogurte.
信息：ICS： CCS：发布：1988-2-1 实施：

GB/T 41907-2022 肠激酶活性检测方法
简介：
信息：ICS：07.080 CCS：C27 发布：2022-10-12 实施：2022-10-12

SN/T 3578-2013 大豆猝死综合症北美种活性检测方法
简介：本标准规定了应用激光扫描共聚焦显微镜对大豆猝死综合症病菌北美种(Fusarium virguliforme O'Donnell et T. Aoki)的活性进行检测的方法。本标准适用于大豆猝死综合症病菌北美种相关寄主中携带的大豆猝死综合症病菌北美种的活性检测鉴定。
信息：ICS： CCS：B16 发布：2013-03-01 实施：2013-09-16

JUS H.P8.063-1988 农药检测．工业用二甲氨荒酸锌．活性成分含量的测定
简介：
信息：ICS： CCS：发布：1988-01-01 实施：

GB/T 40627-2021 油菜茎基溃疡病菌活性检测方法
简介：
信息：ICS：65.020.01 CCS：B16 发布：2021-10-11 实施：2022-05-01 00:00:00.0

SN/T 3579-2013 大豆疫霉病菌活性检测方法
简介：本标准规定了应用激光扫描共聚焦显微镜对大豆疫霉病菌(Phytophthora sojae Kaufmann Gerdemann)的活性进行检测的方法。本标准适用于大豆及土壤中携带的大豆疫霉病菌的活性检测。
信息：ICS： CCS：B16 发布：2013-03-01 实施：2013-09-16

JUS H.P8.104-1988 农药的检测．工业用异丙草胺．活性成分含量的测定．气相色谱法
简介：
信息：ICS： CCS：发布：1988-01-01 实施：

GB/T 40252-2021 美澳型核果褐腐病菌活性检测方法
简介：
信息：ICS：65.020.01 CCS：B16 发布：2021-05-21 实施：2021-12-01 00:00:00.0

NF S92-012-2013 临床实验室试验和体外诊断试验系统 - 检测体外抗菌剂抗传染病中酵母菌活性的标准方法
简介：
信息：ICS：11.100.10 CCS：C47 发布：2013-02-02 实施：2013-02-02

JUS H.P8.069-1988 农药检测．工业用代森锰．活性成分含量的测定
简介：
信息：ICS： CCS：发布：1988-01-01 实施：

GB/T 34795-2017 谷氨酰胺转胺酶活性检测方法
简介：
信息：ICS：07.080 CCS：G66 发布：2017-11-01 实施：2018-05-01 00:00:00.0

BS EN ISO 16256-2012 临床实验室测试和体外诊断测试系统. 检测抗菌剂抗传染病中酵母真菌体外活性的基准方法
简介：
信息：ICS：11.100 CCS：C44 发布：2012-12-31 实施：2012-12-31

JUS H.P8.092-1988 农药检测．工业用西玛三嗪．活性成分含量的测定．气相色谱法
简介：
信息：ICS： CCS：发布：1988-01-01 实施：

GB/T 34799-2017 几丁质酶活性检测方法
简介：
信息：ICS：07.080 CCS：G66 发布：2017-11-01 实施：2018-05-01 00:00:00.0

ISO 16256-2012 临床实验室测试和体外诊断试验系统.检测体外抗菌剂抗传染病中酵母菌的活性的标准方法
简介：
信息：ICS：11.100.10 CCS：C37 发布：2012-12 实施：

JUS H.P8.103-1988 农药检测．工业用甲霜灵．活性成分含量的测定．气相色谱法
简介：
信息：ICS： CCS：发布：1988-01-01 实施：

GB/T 33410-2016 生化试剂中蛋白酶K活性检测方法
简介：
信息：ICS：71.040.30 CCS：G66 发布：2016-12-30 实施：2017-07-01 00:00:00.0

GOST R 55293-2012 酶制剂. 纤维素酶活性检测方法
简介：
信息：ICS：07.100.30 CCS：发布：2012 实施：2014-01-01

JUS H.P8.062-1987 农药检测．二硫代氨基甲酸盐．活性成分含量的测定
简介：
信息：ICS： CCS：发布：1987-01-01 实施：

GB/T 33409-2016 β-半乳糖苷酶活性检测方法分光光度法
简介：
信息：ICS：71.040.30 CCS：G66 发布：2016-12-30 实施：2017-07-01 00:00:00.0

GOST R 55298-2012 酶制剂. 果胶酶活性检测方法
简介：
信息：ICS：07.100.30 CCS：发布：2012 实施：2014-01-01

JUS H.P8.045-1985 农药检测．均三嗪．活性成分含量的测定
简介：
信息：ICS： CCS：发布：1985-01-01 实施：

GB/T 32131-2015 辣根过氧化物酶活性检测方法比色法
简介：本标准规定了辣根过氧化物酶活性检测方法。本标准适用于生化试剂、工业产品中辣根过氧化物酶活性的测定。
信息：ICS：07.080 CCS：G62 发布：2015-10-09 实施：2016-03-01

GOST R 55302-2012 酶制剂. 木聚糖酶活性检测方法
简介：
信息：ICS：07.100.30 CCS：发布：2012 实施：2014-01-01

NBN V 21-033-1983 奶粉．磷酸酶活性的检测
简介：La présente norme décrit un mode opéra-toire pour la détermination de l'activi-té de la phosphatase alcaline dans le lait en poudre.
信息：ICS： CCS：发布：1984-1-5 实施：

GB/T 30990-2014 溶菌酶活性检测方法
简介：本标准规定了溶菌酶活性检测方法。本标准适用于生化试剂、不同工业产品及其原料中溶菌酶活性的测定。
信息：ICS：07.080 CCS：G60 发布：2014-07-24 实施：2015-03-01

GOST R 53973-2010 酶制剂.β-葡聚糖酶活性的检测方法
简介：
信息：ICS：07.100.30 CCS：发布：2010 实施：2012-01-01

MSZ 3245/1-1984 活性沥青检测．沥青检测
简介：
信息：ICS： CCS：发布：1984 实施：

GB/T 20929-2007 嗜酸氧化亚铁硫杆菌及其活性的基因芯片检测方法
简介：本标准规定了利用基因芯片技术检测嗜酸氧化亚铁硫杆菌（以下简称 A.f 菌）及其活性的术语、定义、符号、省略语、主要技术指标和待测样品的要求、样品图谱的制作及分析方法。本标准适用于利用基因芯片技术来高效快速的鉴别 A.f 菌，并确定待测样品中 A.f 菌株的氧化活性。
信息：ICS：07.100.01 CCS：C27;D16 发布：2007-04-30 实施：2007-11-01

GOST R 53360-2009 酶制剂.植酸酶活性的检测方法
简介：
信息：ICS：07.100.30;65.120 CCS：C53 发布：2009 实施：2010-01-01

MSZ 14160/14-1982 洗衣剂基础物质和洗衣剂检测，合成物阴离子活性物质含量测定
简介：
信息：ICS： CCS：发布：1982 实施：

T/CSTM 01090-2022 乙酰胆碱酯酶活性检测分光光度法
简介：本文件规定了用分光光度法测定乙酰胆碱酯酶活性的方法。本文件适用于有机磷与氨基甲酸酯类农药残留检测专用试剂中乙酰胆碱酯酶活性的测定，本方法定量限为0.01μmol/(mL·min)，测量范围为0.01μmol/(mL·min)~0.13μmol/(mL·min)。
信息：ICS：71.040.30 CCS：C266 发布：2022-10-28 实施：2022-10-28

KS J 4206-2008 对抗菌功能产品的抗菌活性检测方法.第1部分:摇瓶法
简介：이 표준은 항균 기능이 부여된 항균 제품(이하 제품이라고 한다.)의 진탕 플라스크에 의한
信息：ICS： CCS：C27 发布：2008-11-06 实施：2008-11-06

MSZ 6943/6-1981 蜂蜜的散活性检测以及物理和化学检验
简介：
信息：ICS： CCS：发布：1981 实施：

T/CAIA SHO19-2022 乙酰胆碱酯酶活性检测分光光度法
简介：乙酰胆碱酯酶能水解碘化硫代乙酰胆碱生成硫代胆碱和乙酸。硫代胆碱与巯基显色剂5,5'-二硫代双（2-硝基苯甲酸）（DTNB）反应生成黄色化合物5-巯基-2-硝基苯甲酸（TNB），TNB在波长412nm处有特征性光吸收，测定其吸光度值；根据还原型谷胱甘肽制备标准溶液与DTNB反应，所绘制谷胱甘肽的量与吸光度关系的标准曲线，计算出乙酰胆碱酯酶的酶活性值。
信息：ICS：67.050 CCS：M733 发布：2022-10-25 实施：2022-10-27

YY/T 0688.1-2008 临床实验室检测和体外诊断系统.感染病源体敏感性试验与抗菌剂敏感性试验设备的性能评价.第1部分：抗菌剂对感染性疾病相关的快速生长需氧菌的体外活性检测的参考方法
简介：YY/T 0688的本部分介绍了测定抗菌剂MIC值的一种参考方法—肉汤微量稀释法。MIC值仅反映抗菌剂在规定的体外试验条件下的抗菌活性。医生在制定用药方案时，不但要参考MIC结果，还应考虑诸如药物在人体内的药代/药效学参数以及细菌对抗菌剂的耐药机制等其他因素。对于某种抗菌剂，根据体外敏感性试验结果(MIC值)可将相应受试菌划分为"敏感(S)"、"中介I)"和"耐药(R)"。另外，MIC值可用于确定该受试菌株是野生型还是非野生型。尽管解释MIC值的临床意义已超出了本部分的范畴，但为了适应临床需要，根据不同抗菌剂-细菌组合对方法的基本内容进行调整是必要的。这些调整体现在下列各表格中。为了确保试验结果的可比性与可靠性，其他药敏试验方法(如常规方法或抗菌剂敏感性试验设备)应该和本参考方法进行比对以确定其准确性。
信息：ICS：11.100 CCS：C44 发布：2008-10-17 实施：2010-01-01

MSZ 19397-1980 建筑材料自然放射活性检测
简介：
信息：ICS： CCS：发布：1980-01-01 实施：

ASTM E1447-22 用热导率或红外光谱法检测的惰性气体熔融法测定活性金属和活性金属合金中氢的标准试验方法
简介：
信息：ICS：77.120.50 CCS：发布：2022-06-01 实施：

GOST R 53047-2008 酶制剂.木聚糖酶发酵活性检测方法
简介：
信息：ICS：07.100.30;65.120 CCS：C54 发布：2008 实施：2010-01-01

MSZ 6230/9-1980 活性物质检测．非煤商家的检测一部分，多环芳烃检测
简介：
信息：ICS： CCS：发布：1980 实施：

YY/T 1728-2021 临床实验室检测和体外诊断系统感染性疾病相关酵母样真菌抗菌剂的体外活性检测参考方法
简介：
信息：ICS：11.100 CCS：C44 发布：2021-03-09 实施：2022-04-01

BS DD ISO/TS 6090-2005 牛奶和奶粉、脱脂乳和脱脂奶粉、乳清和乳清粉.磷酸酶活性检测
简介：
信息：ICS：67.100.01;67.100.10 CCS：X16 发布：2005-01-05 实施：2005-05-01

MSZ 6230/10-1980 活性元素检测．砷含量定义
简介：
信息：ICS： CCS：发布：1980 实施：

ISO 21676:2018 水质.水和处理废水中选定活性药物成分、转化产物和其他有机物质的溶解分数的测定.直接注射后使用高效液相色谱和质谱检测（HPLC-MS/MS或-HRMS）的方法
简介：
信息：ICS：13.060.50 CCS：发布：2018-10-15 实施：

ASTM E2271-2005a 独院住宅和儿童设施中随着铅危害活性降低检测安全距离的标准实施规程
简介：A clearance examination of abatement areas and other areas associated with other lead-hazard control activities, or building maintenance or modification activities in single-family detached dwellings, multifamily dwellings having similar units, common areas or exterior sites, and child-occupied facilities is performed to determine that the clearance area is adequately safe for reoccupancy. It is the responsibility of the user of this standard to assure that all regulatory, contractual, and personnel requirements are met prior to conduct of a clearance examination. At a minimum, users of this standard shall be trained in its use and in safe practices for its conduct. This practice is one of a set of standards developed for lead hazard management activities. The visual assessment procedures required in this standard are found in Practice E 2255 and the record keeping requirements are found in Practice E 2239. Although this practice was primarily developed for dwellings and for other child-occupied facilities, this practice may be also applied to nonresidential buildings and related structures by agreement between the client and the individual conducting the clearance examination. This practice may be used by owners and property managers, including owner-occupants, and others responsible for maintaining facilities. It may also be used by lead hazard management consultants, construction contractors, labor groups, real estate and financial professionals, insurance organizations, legislators, regulators, and legal professionals. This standard does not address whether lead-hazard reduction activities or other building modification or maintenance work were done properly.1.1 This practice combines visual assessment for the presence of deteriorated paint, surface dust, painted debris, and paint chips with environmental sampling of surface dust to determine whether a lead hazard exists at the time of sample collection, following abatement, other lead-hazard reduction activities, or building maintenance or modification activities.1.2 This practice addresses clearance examination of single-family residential dwellings and child-occupied facilities.1.3 This practice also addresses clearance examinations that may include soil sampling, for example when soil abatement has been performed.1.4 This practice includes a procedure for determining whether regulatory requirements for lead clearance levels for dust and, where warranted, soil have been met, and, consequently whether a clearance area, passes or fails a clearance examination.Note 18212;This practice is consistent with that portion of "clearance" described in 40 CFR Part 745 for abatement, and in 24 CFR 35 for lead-hazard reduction activities other than abatement.1.5 The values stated in SI units are to be regarded as the standard.1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
信息：ICS：13.080.10 (Chemical characteristics of soil); 91.0 CCS：P04 发布：2005 实施：

MSZ 6369/13-1979 面粉检测模式．白色含量定义以及活性元素含量定义
简介：
信息：ICS： CCS：发布：1979 实施：

KS P ISO 16256-2017 临床实验室检测和体外诊断检测系统─检测抗菌药物对感染酵母菌的体外活性的参考方法
简介：
信息：ICS： CCS：发布：2017-12-29 实施：

ASTM E2271-2005 独院住宅和儿童设施中随着铅危害活性降低检测安全距离的标准实施规程
简介：1.1 This practice combines visual assessment for the presence of deteriorated paint, surface dust, painted debris, and paint chips with environmental sampling of surface dust to determine whether a lead hazard exists at the time of sample collection, following abatement, other lead-hazard reduction activities, or building maintenance or modification activities.1.2 This practice addresses clearance examination of single-family residential dwellings and child-occupied facilities.1.3 This practice also addresses clearance examinations that may include soil sampling, for example when soil abatement has been performed.1.4 This practice includes a procedure for determining whether regulatory requirements for lead clearance levels for dust and, where warranted, soil have been met, and, consequently whether a clearance area, passes or fails a clearance examination.Note 18212;This practice is consistent with that portion of "clearance" described in 40 CFR Part 745 for abatement, and in 24 CFR 35 for lead-hazard reduction activities other than abatement.1.5 The values stated in SI units are to be regarded as the standard.1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
信息：ICS：13.080.10 (Chemical characteristics of soil); 91.0 CCS：P04 发布：2005 实施：

MSZ MI 19376-1977 水中β射线同位素活性检测
简介：
信息：ICS： CCS：发布：1977-01-01 实施：

GOST R ISO 16256-2015 临床实验室测试和体外诊断测试系统. 检测抗菌剂抗传染病中酵母真菌体外活性的基准方法
简介：
信息：ICS：11.100.10 CCS：发布：2015 实施：2016-06-01

ASTM E2271-2005a(2012)e1 住宅和其他儿童设施中随着铅危害活性降低检测安全距离的标准实施规程
简介：A clearance examination of abatement areas and other areas associated with other lead-hazard control activities, or building maintenance or modification activities in single-family detached dwellings, multifamily dwellings having similar units, common areas or exterior sites, and child-occupied facilities is performed to determine that the clearance area is adequately safe for reoccupancy. It is the responsibility of the user of this standard to assure that all regulatory, contractual, and personnel requirements are met prior to conduct of a clearance examination. At a minimum, users of this standard shall be trained in its use and in safe practices for its conduct. This practice is one of a set of standards developed for lead hazard management activities. The visual assessment procedures required in this standard are found in Practice E2255 and the record keeping requirements are found in Practice E2239. Although this practice was primarily developed for dwellings and for other child-occupied facilities, this practice may be also applied to nonresidential buildings and related structures by agreement between the client and the individual conducting the clearance examination. This practice may be used by owners and property managers, including owner-occupants, and others responsible for maintaining facilities. It may also be used by lead hazard management consultants, construction contractors, labor groups, real estate and financial professionals, insurance organizations, legislators, regulators, and legal professionals. This standard does not address whether lead-hazard reduction activities or other building modification or maintenance work were done properly.1.1 This practice covers visual assessment for the presence of deteriorated paint, surface dust, painted debris, and paint chips with environmental sampling of surface dust to determine whether a lead hazard exists at the time of sample collection, following lead-hazard reduction activities, or other building maintenance and modification activities. 1.2 This practice addresses clearance examination of single-family detached dwellings (including exterior structures, such as fences), multifamily dwellings having similar units, common areas or exterior sites, and child-occupied facilities. 1.3 This practice also addresses clearance examinations that may include soil sampling, for example when soil abatement has been performed. 1.4 This practice includes a procedure for determining whether regulatory requirements for lead clearance levels for dust and, where warranted, soil have been met, and, consequently whether a clearance area, passes or fails a clearance examination. Note 18212;This practice is based on that portion of x201C;clearancex201D; described in 40 CFR Part 745 for abatement, and in 24 CFR 35 for lead-hazard reduction activities other than abatement, except that composite dust sampling is not used. 1.5 The values stated in SI units are to be regarded as standard. The values given in parentheses are mathematical conversions to inch-pound units that are provided for information only and are not considered standard. 1.6 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
信息：ICS：13.080.10 (Chemical characteristics of soil); 91.0 CCS：P33 发布：2005 实施：

MSZ MI 19386-1977 水中伽马射线同位素活性检测
简介：
信息：ICS： CCS：发布：1977-01-01 实施：

NF G39-021-2014 纺织品. 纺织品抗病毒活性检测的测定
简介：La présente Norme internationale spécifie des méthodes d'essai permettant d'évaluer l'activité virucide des produits textiles. Les produits textiles incluent les tissus, les tricots, les fibres, les fils, les tresses, etc.
信息：ICS：07.100.99;59.080.01 CCS：发布：2014-10-24 实施：2014-10-24

ISO/TS 6090:2004 牛奶和奶粉、酪乳和酪乳粉、乳清和乳清粉.磷酸酶活性的检测
简介：
信息：ICS：67.100.01 CCS：发布：2004-03-09 实施：

MSZ 14160/9.lap-1969 洗衣剂基础物质和洗衣剂检测．含表面活性物质制成品特性检测
简介：
信息：ICS： CCS：发布：1969 实施：

ISO/TS 17796:2013 橡胶——在聚（2,6-二苯基苯氧基）型吸附剂上采用热脱附和气相色谱法和质谱检测通过活性取样捕获和识别橡胶烟雾的挥发性成分
简介：
信息：ICS：83.060 CCS：发布：2013-06-19 实施：

ISO/TS 6090-2004 奶和奶粉、酪乳和酪乳粉、乳清和乳清粉.磷酸酶活性的检测
简介：This Technical Specification specifies a screening method for the detection of the phosphatase activity in cow's milk and dried milk, buttermilk and buttermilk powder, and whey and whey powder.Two alternative procedures (A and B) are given. Procedure A is the simpler as it does not include a clarification treatment and is especially suited for milk. Procedure B includes a clarification step which allows a more sensitive detection through which better quantitative results can be obtained, if desired.If either method is used for checking the proper pasteurization of these products or their raw materials, then further tests are necessary to ensure that the phosphatase activity is not due to either heat-stable microbial phosphatase (see 9.3.1) or reactivated phosphatase (see 9.3.2).NOTE A method using a patented proprietary reagent is described in Annex A.
信息：ICS：67.100.01;67.100.10 CCS：X16 发布：2004-03 实施：

MSZ 14160/6.lap-1968 洗衣剂基础物质和洗衣剂检测．洗涤活性物质含量测定
简介：
信息：ICS： CCS：发布：1968 实施：